Preclinical drug testing for clinical trial planning of novel combinative therapy with PI3K and MAPK inhibitors in colorectal cancer(CRC). This is an ASCO Meeting Abstract from the 2020 ...
Phase 2/3, randomized, open-label study of an individualized neoantigen vaccine (self-amplifying mRNA and adenoviral vectors) plus immune checkpoint blockade as maintenance for patients with newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results